Carolyn Rucci
General Counsel bei AKEBIA THERAPEUTICS, INC.
Profil
Carolyn M.
Rucci is currently the Senior Vice President-Legal & General Counsel at Akebia Therapeutics, Inc. Prior to her current position, she served as the Vice President & Deputy General Counsel at AMAG Pharmaceuticals, Inc. from 2016 to 2021.
She also worked as a Principal at Wilmer Cutler Pickering Hale & Dorr LLP.
Ms. Rucci holds a graduate degree from Boston University School of Law and an undergraduate degree from Trinity College.
Aktive Positionen von Carolyn Rucci
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | General Counsel | 01.01.2021 |
Ehemalige bekannte Positionen von Carolyn Rucci
| Unternehmen | Position | Ende |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | General Counsel | 01.01.2021 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Ausbildung von Carolyn Rucci
| Trinity College | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
